Koers Myovant Sciences Ltd.
Aandelen
MYOV
BMG637AM1024
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 04-01-21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 27-12-19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 27-12-19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 04-01-21 |
Director/Board Member | 59 | 22-10-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.11% | 0 M€ | 0,00% | - | |
0.08% | 0 M€ | 0,00% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,30% | 46,03 mld. | |
+52,73% | 44,55 mld. | |
+7,15% | 40,8 mld. | |
-8,78% | 28,25 mld. | |
+18,68% | 27,71 mld. | |
-21,92% | 18,82 mld. | |
+14,62% | 13,91 mld. | |
+31,85% | 12,43 mld. | |
-8,77% | 11,06 mld. |